Literature DB >> 16551504

A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugs.

S G Uijl1, C S M P Uiterwaal, A P Aldenkamp, J A Carpay, J C Doelman, K Keizer, C J Vecht, M C de Krom, C A van Donselaar.   

Abstract

OBJECTIVES: Side-effects of anti-epileptic drugs (AEDs) may be overlooked in patients with epilepsy in everyday clinical practice. The aim of this study was to assess the prevalence and severity of subjective complaints in patients who were considered to be well-controlled and to assess whether these complaints are related to medication, personality traits, or other determinants.
METHODS: We included patients with epilepsy who were considered to be well-controlled in a cross-sectional study in seven hospitals in the Netherlands. Their medication had not been changed for six months and an apparent reason to change the medication was lacking at the time of enrolment. Subjective complaints were assessed with a 46-item questionnaire. Using multivariable linear regression modeling, we assessed whether patient characteristics, epilepsy characteristics, medication, quality of life (Qolie-10), and personality traits (SCL-90) explained the presence and severity of complaints.
RESULTS: Of 173 included patients, 67% reported moderate to severe subjective complaints on the questionnaire. Cognitive complaints were reported most frequently. Multivariate modeling showed that 61% of the variance in reported complaints could be explained by included determinants. The prevalence and severity of complaints was associated with AED polytherapy and higher scores on psycho neuroticism.
CONCLUSIONS: Patients who were considered to be well-controlled proved to report an unexpectedly high number of subjective complaints. Both medication and aspects of personality contributed to the level of complaints. Our study illustrates that subjective side-effects are easily overlooked in everyday clinical practice, possibly because in practice a generally phrased question is used to detect side-effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551504     DOI: 10.1016/j.seizure.2006.02.009

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  17 in total

1.  Patient-Reported Adverse Effects Associated with Combination Antiretroviral Therapy and Coadministered Enzyme-Inducing Antiepileptic Drugs.

Authors:  Melissa A Elafros; Gretchen L Birbeck; Joseph C Gardiner; Omar K Siddiqi; Izukanji Sikazwe; Nigel Paneth; Christopher M Bositis; Jason F Okulicz
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Do We Know What We Think We Know? Reconciling Subjective Complaints and Objective Cognitive Testing in Older Adults With Epilepsy.

Authors:  Adriana Bermeo-Ovalle
Journal:  Epilepsy Curr       Date:  2016 Jul-Aug       Impact factor: 7.500

3.  Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece.

Authors:  Charitomeni Piperidou; Anna Karlovasitou; Nikolaos Triantafyllou; Evagelia Dimitrakoudi; Aikaterini Terzoudi; Eleni Mavraki; Grigorios Trypsianis; Konstantinos Vadikolias; Ioannis Heliopoulos; Dimitrios Vassilopoulos; Stavros Balogiannis
Journal:  Qual Life Res       Date:  2008-07-29       Impact factor: 4.147

Review 4.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

5.  Subjective perception of cognition is related to mood and not performance.

Authors:  S E Marino; K J Meador; D W Loring; M S Okun; H H Fernandez; A J Fessler; R P Kustra; J M Miller; P G Ray; A Roy; M R Schoenberg; V J Vahle; M A Werz
Journal:  Epilepsy Behav       Date:  2009-01-06       Impact factor: 2.937

6.  Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10 years?

Authors:  Merel Wassenaar; Inger van Heijl; Frans S S Leijten; Paul van der Linden; Sabine G Uijl; A C G Egberts; J A Carpay
Journal:  J Neurol       Date:  2013-07-28       Impact factor: 4.849

Review 7.  Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements.

Authors:  Annabel Nixon; Cicely Kerr; Katie Breheny; Diane Wild
Journal:  Health Qual Life Outcomes       Date:  2013-03-11       Impact factor: 3.186

8.  Medication monitoring for people with dementia in care homes: the feasibility and clinical impact of nurse-led monitoring.

Authors:  Sue Jordan; Marie Gabe; Louise Newson; Sherrill Snelgrove; Gerwyn Panes; Aldo Picek; Ian T Russell; Michael Dennis
Journal:  ScientificWorldJournal       Date:  2014-02-23

9.  Pattern of adverse events of antiepileptic drugs: results of the aESCAPE study in Poland.

Authors:  Barbara Chmielewska; Krystyna Lis; Konrad Rejdak; Marcin Balcerzak; Barbara Steinborn
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

Review 10.  Rational Polytherapy with Antiepileptic Drugs.

Authors:  Jong Woo Lee; Barbara Dworetzky
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.